Western Pharma Giants Paid Millions to Russian Distributors Linked to Fraud, Whistleblower Report Says

The payments by Merck, Eli Lilly, Novartis and AstraZeneca allegedly helped fund a corruption scheme that kept drug prices high and limited competition across Russia’s public healthcare system.

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.